Iron Surveillance and Management in Gastro-Intestinal Oncology Patients: A National Physician Survey

被引:0
|
作者
Richard, Emilie S. [1 ]
Hrycyshyn, Adriyan [1 ]
Salman, Noor [1 ]
Remtulla Tharani, Alliya [1 ]
Abbruzzino, Alexandria [1 ]
Smith, Janet [1 ]
Kachura, Jacob J. [1 ]
Sholzberg, Michelle [2 ,3 ]
Mosko, Jeffrey D. [3 ,4 ]
Chadi, Sami A. [5 ,6 ]
Burkes, Ronald L. [1 ,3 ]
Pankiw, Maya [1 ]
Brezden-Masley, Christine [1 ,3 ]
机构
[1] Mt Sinai Hosp, Dept Med, Sinai Hlth, Toronto, ON M5G 1X5, Canada
[2] St Michaels Hosp, Dept Med, Div Oncol Hematol, Unity Hlth Toronto, Toronto, ON M5B 1W8, Canada
[3] Univ Toronto, Temerty Fac Med, Dept Med, Toronto, ON M5S 3H2, Canada
[4] St Michaels Hosp, Dept Med, Div Gastroenterol, Unity Hlth Toronto, Toronto, ON M5B 1W8, Canada
[5] Univ Hlth Network, Toronto Gen Hosp, Sprott Dept Surg, Div Gen Surg, Toronto, ON M5G 2C4, Canada
[6] Univ Toronto, Dept Surg, Toronto, ON M5T 1P5, Canada
关键词
iron deficiency; iron deficiency anemia; anemia; gastrointestinal cancer; CHEMOTHERAPY-INDUCED ANEMIA; COLORECTAL-CANCER PATIENTS; DEFICIENCY ANEMIA; PREVALENCE; IMPACT; SUPPLEMENTATION; DIAGNOSIS; ADULTS; TUMORS;
D O I
10.3390/curroncol30110714
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Iron deficiency (ID) is a complication of gastrointestinal (GI) cancers that may manifest as iron deficiency anemia (IDA). Serum ferritin monitoring and oral iron supplementation have the limitations of being falsely elevated and poorly absorbed, respectively. This study aims to assess the discordance in surveillance, treatment practices, and awareness of ID/IDA in GI cancer patients by Canadian physicians treating these patients. Methods: From February 2020 to September 2021, a 22-question electronic survey was sent to medical oncologists (MOs), surgical oncologists (SOs), and gastroenterologists (GEs). The survey collected information about four domains: physician demographics, surveillance practices, treatment practices, and awareness of ID/IDA in GI cancer patients and ASCO/ASH guidelines. Results: A total of 108 (34 MOs, 19 SOs, and 55 GEs) of the 872 (12.4%) invited physicians completed the survey. Of these, 26.5% of MOs, 36.8% of SOs, and 70.9% of GEs measured baseline iron parameters, with few continuing surveillance throughout treatment. Ferritin was widely measured by MOs (88.9%), SOs (100%), and GEs (91.4%). Iron was supplemented if ID/IDA was identified pre-treatment by 66.7% of MOs, 85.7% of SOs, and 94.2% of GEs. Parenteral iron was prescribed by SOs (100%), while oral iron was prescribed by MOs (83.3%) and GEs (87.9%). Only 18.6% of physicians were aware of the ASCO/ASH guidelines regarding erythropoiesis-stimulating agents with parenteral iron for treating chemotherapy-induced anemia. Conclusion: Results illustrate variations in practice patterns for IDA management across the different physician specialties. Moreover, there appeared to be gaps in the knowledge and care surrounding evidence-based IDA management principles which may contribute to poor clinical outcomes.
引用
收藏
页码:9836 / 9848
页数:13
相关论文
共 50 条
  • [1] The management of patients with new onset of upper gastro-intestinal symptoms in primary care
    Tosetti, Cesare
    Bellentani, Stefano
    Benedetto, Edoardo
    Ubaldi, Enzo
    Cardin, Fabrizio
    Bozzani, Alberto
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (12) : 860 - 864
  • [2] Ovotransferrin Supplementation Improves the Iron Absorption: An In Vitro Gastro-Intestinal Model
    Galla, Rebecca
    Grisenti, Paride
    Farghali, Mahitab
    Saccuman, Laura
    Ferraboschi, Patrizia
    Uberti, Francesca
    BIOMEDICINES, 2021, 9 (11)
  • [3] An abattoir survey of gastro-intestinal nematodes in sheep in the Burdur region, Turkey
    Umur, S
    Yukari, BA
    TURKISH JOURNAL OF VETERINARY & ANIMAL SCIENCES, 2005, 29 (05) : 1195 - 1201
  • [4] Micronutrient Food Supplements in Patients with Gastro-Intestinal and Hepatic Cancers
    Alam, Waqas
    Ullah, Hammad
    Santarcangelo, Cristina
    Di Minno, Alessandro
    Khan, Haroon
    Daglia, Maria
    Arciola, Carla Renata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [5] EFFECT OF IMMUNOCHEMOTHERAPY ON LYMPHOCYTE-RESPONSE OF PATIENTS WITH GASTRO-INTESTINAL CANCER
    MASHIBA, H
    YOSHINAGA, H
    MATSUNAGA, K
    GOJOBORI, M
    FURUSAWA, M
    JOURNAL OF SURGICAL ONCOLOGY, 1979, 12 (03) : 275 - 279
  • [6] Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastro-intestinal symptoms
    Tauber, M.
    Avouac, J.
    Benahmed, A.
    Barbot, L.
    Coustet, B.
    Kahan, A.
    Allanore, Y.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (06) : S82 - S87
  • [7] A survey of gastro-intestinal parasitic infection in domestic and wild birds in Chittagong and Greater Sylhet, Bangladesh
    Hoque, Md. Ahasanul
    Hassan, Mohammad Mahmudul
    Hague, Enamul
    Shaikat, Amir Hossan
    Khan, Shahneaz Ali
    Alim, Abdul
    Skerratt, Lee Francis
    Islam, Ariful
    Tun, Hein Min
    Dissanayake, Ravi
    Day, Tapan Kumar
    Debnath, Nitish Chandra
    Yamage, Mat
    PREVENTIVE VETERINARY MEDICINE, 2014, 117 (01) : 305 - 312
  • [8] Survey of ovine and caprine gastro-intestinal helminthosis in eastern part of Ethiopia during the dry season of the year
    Abebe, W
    Esayas, G
    REVUE DE MEDECINE VETERINAIRE, 2001, 152 (05) : 379 - 384
  • [9] Management of Iron Deficiency Anemia: A Survey of Pediatric Hematology/Oncology Specialists
    Powers, Jacquelyn M.
    McCavit, Timothy L.
    Buchanan, George R.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (05) : 842 - 846
  • [10] SOME ASPECTS OF SOCIAL AND WORKING REHABILITATION OF PATIENTS WITH GASTRO-INTESTINAL TUMORS AFTER RADICAL OPERATIONS
    SIMONOV, NN
    GNEZDILOV, AV
    BERJOZKIN, DP
    MEDICAL AND PEDIATRIC ONCOLOGY, 1979, 7 (02): : 103 - 109